ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758965; 2) Community: the network communities that were significantly associated with the response to NSC 758965; 3) Molecule: the relationships between components within communities and NSC 758965; 4) MDR: the compounds that were significantly associated with the NSC 758965.

NSC Compound Enrichment Correlation
NSC 697535 Null 0.0480633950058471 0.08871344
NSC 715407 Null 0.0480633950058471 0.25602416
NSC 716002 Null 0.0480633950058471 0.21396511
NSC 718781 Erlotinib hydrochloride 0.0480633950058471 -0.42960214
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0480633950058471 0.45907251
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058471 0.40231238
NSC 752346 Null 0.0480633950058471 0.19850665
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0480633950058475 0.31927708
NSC 276371 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- 3.31921050119509e-005 0.1427038
Total:52  Current:52    [First] [Prev] [Next] [Last]